Advertisement
Advertisement
WVE
Wave Life Sciences Ltd. Ordinary Shares
12.29
USDSponsored
+0.65
+5.63%
Mar 25, 15:59 UTC -4
Closed
After-Market
12.34
+0.05
+0.45%
WVE Earnings Reports
Positive Surprise Ratio
WVE beat 9 of 41 last estimates.
22%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$9.10M
/-$0.33
Implied change from Q4 25 (Revenue/ EPS)
-47.21%
/+10.00%
Implied change from Q1 25 (Revenue/ EPS)
-0.79%
/+17.86%
Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue
On Feb 26, 2026, WVE reported earnings of -0.30 USD per share (EPS) for Q4 25, missing the estimate of -0.27 USD, resulting in a -9.97% surprise. Revenue reached 17.24 million, compared to an expected 16.46 million, with a 4.76% difference. The market reacted with a +5.64% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of -0.33 USD, with revenue projected to reach 9.10 million USD, implying an increase of 10.00% EPS, and decrease of -47.21% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
FAQ
What were Wave Life Sciences Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.30, missing estimates by -9.97%, and revenue of $17.24M, 4.76% above expectations.
How did the market react to Wave Life Sciences Ltd. Ordinary Shares's Q4 2025 earnings?
The stock price moved up 5.64%, changed from $14.54 before the earnings release to $15.36 the day after.
When is Wave Life Sciences Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Wave Life Sciences Ltd. Ordinary Shares's next earnings report?
Based on 12
analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.33 and revenue of $9.10M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement